問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

鐘達榮
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2014-02-01 - 2015-11-01

Phase III

A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
  • Condition/Disease

    Community-Acquired Bacterial Pneumonia

  • Test Drug

    Solithromycin (CEM-101)

Participate Sites
2Sites

Terminated1Sites

Study ended1Sites